BOLERO-3 Safety Analysis Finds Everolimus Regimen Is Manageable – OncLive
OncLiveBOLERO-3 Safety Analysis Finds Everolimus Regimen Is ManageableOncLiveThe combination of everolimus, trastuzumab, and vinorelbine, as given in the BOLERO-3 trial in patients with pretreated HER2-positive advanced breast cancer, is adequately tol…